[Preventive medicine: costs and responsibilities of insurance companies].
Under the provisions of the Health Insurance Law (KVG), the costs of preventive medicine are to be borne by the mandatory health insurance. Although it has been defined who shall be responsible for taking the necessary measures, concrete objectives have yet to be established. This is giving rise to difficulties in the implementation of the law. The author discusses basic questions relating to this situation: The nature of the preventive measures (GENOME Analysis), and the economic efficiency. An insight is also given into the work of the Preventive Medicine Services Subcommittee of the Federal Service-Providing Committee (Subkommission Präventive Leistungen der Eidgenössischen Leistungskommission) and the criteria adopted.
Brunner
H H
HH
Verbindung der Schweizer Arzte FMH, Bern.
D003362:Cost-Benefit Analysis / Q000331:legislation & jurisprudence; D006801:Humans; D007342:Insurance Benefits / Q000191:economics* / Q000331:legislation & jurisprudence; D008403:Mass Screening / Q000191:economics* / Q000331:legislation & jurisprudence; D009313:National Health Programs / Q000191:economics* / Q000331:legislation & jurisprudence; D011322:Primary Prevention / Q000191:economics* / Q000331:legislation & jurisprudence; D013557:Switzerland
Präventionsmedizin: Kosten und Leistungen der Versicherer.